RESEARCH: Co-Morbidity & Opportunistic Infections
A5265: A Phase III, Open-Label, Randomized, Assessment-Blinded Clinical Trial to Compare the Safety and Efficacy of Topical Gentian Violet to that of Nystatin Oral Suspension for the Treatment of Oropharyngeal Candidiasis in HIV-1 Infected Participants in Non-US Settings (An ACTG Study)
BHP046
Principal Investigator: Aida Asmelash
Funding: NIH
Objectives:
Enrollment Start: August 2011